Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1995-7-6
|
pubmed:abstractText |
Renal endothelin-1 (ET-1) production is diminished in spontaneously hypertensive rats. An increase has been reported of renal ET-1 production associated with progression of renal disease in rats with reduced renal mass. The purpose of the present study was to investigate the evolution over time of the urinary ET-1 excretion in an experimental model of renal mass reduction not caused by renal infarction. Rats were subjected to 2/3 nephrectomy (right nephrectomy and resection of the lower left renal pole) and thereafter randomly assigned to a no-treatment control group or to treatment with recombinant erythropoietin, recombinant erythropoietin plus verapamil, or recombinant erythropoietin plus enalapril. The urinary ET-1 excretion was decreased by week 16 after nephrectomy as compared with healthy animals and with the levels 6 weeks after nephrectomy. The temporal evolution of urinary ET-1 excretion in the various groups of rats showed a trend toward decrease in all groups except the one receiving enalapril. The urinary ET-1 excretion correlated directly with creatinine clearance and inversely with tubulointerstitial damage. We observed an inverse correlation between urinary ET-1 excretion and arterial blood pressure 16 weeks after nephrectomy. These results indicate that renal ET-1 production decreases with the progression of renal disease and in relation with the severity of tubulointerstitial damage. The decrease in renal ET-1 production might contribute to the development and perpetuation of renal disease-associated arterial hypertension; this situation may be favorably modified by the use of enalapril.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Enalapril,
http://linkedlifedata.com/resource/pubmed/chemical/Endothelins,
http://linkedlifedata.com/resource/pubmed/chemical/Erythropoietin,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Verapamil
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0272-6386
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
918-23
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7771489-Animals,
pubmed-meshheading:7771489-Enalapril,
pubmed-meshheading:7771489-Endothelins,
pubmed-meshheading:7771489-Erythropoietin,
pubmed-meshheading:7771489-Hypertension, Renal,
pubmed-meshheading:7771489-Kidney,
pubmed-meshheading:7771489-Kidney Diseases,
pubmed-meshheading:7771489-Male,
pubmed-meshheading:7771489-Nephrectomy,
pubmed-meshheading:7771489-Radioimmunoassay,
pubmed-meshheading:7771489-Rats,
pubmed-meshheading:7771489-Rats, Wistar,
pubmed-meshheading:7771489-Recombinant Proteins,
pubmed-meshheading:7771489-Verapamil
|
pubmed:year |
1995
|
pubmed:articleTitle |
Alterations in renal endothelin production in rats with reduced renal mass.
|
pubmed:affiliation |
Nephrology Service, San Carlos University Hospital, Madrid, Spain.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|